Skip to main content
Clinical Trials/NCT00675610
NCT00675610
Completed
Phase 3

Enhancing Communication and HIV Outcomes

Johns Hopkins University3 sites in 1 country186 target enrollmentMay 2008
ConditionsHIV Infections

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
HIV Infections
Sponsor
Johns Hopkins University
Enrollment
186
Locations
3
Primary Endpoint
patient-provider communication
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The goal of this research is to improve communication between the patients with HIV and their health care providers. The overall purpose of doing so is to reduce disparities in medication self-efficacy, adherence to therapy, and HIV viral load suppression. The investigators will conduct a randomized controlled trial to test the effectiveness of a combined provider and patient communication intervention conducted at two separate visits compared to usual care in improving the quality of patient-provider communication, patients' medication self-efficacy, patient adherence to therapy, and HIV RNA suppression.

Detailed Description

The goal of this research is to improve communication between the patients with HIV and their health care providers. The overall purpose of doing so is to reduce disparities in medication self-efficacy, adherence to therapy, and HIV viral load suppression. We will conduct a randomized controlled trial to test the effectiveness of a combined provider and patient communication intervention conducted at two separate visits compared to usual care in improving the quality of patient-provider communication, patients' medication self-efficacy, patient adherence to therapy, and HIV RNA suppression. The following primary and secondary hypotheses will be addressed. Primary Hypothesis. 1) There will be more and higher quality patient-provider communication about antiretroviral medication adherence in the intervention compared to control arm at both visit 1 (V1) and visit 2 (V2). Secondary Hypotheses 1. Higher quality patient-provider communication in the intervention arm will be associated with * higher patient ratings of communication (overall, HIV-specific, adherence-specific, and interpersonal style of provider) at V1 and V2; * increased patient preference for a shared decision-making role at V1 and V2; * more positive health beliefs at V1 and V2; * higher patient medication self-efficacy at V1 and V2; * better adherence to antiretroviral medication (assessed by 3-day recall) at V2; and * a greater percentage of patients with HIV-1 RNA suppression at V2. 2. The intervention will reduce disparities in medication self-efficacy, adherence, and HIV-1 RNA suppression.

Registry
clinicaltrials.gov
Start Date
May 2008
End Date
May 2010
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mary Catherine Beach

Associate Professor

Johns Hopkins University

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

patient-provider communication

Time Frame: 1 day- 3 months

Study Sites (3)

Loading locations...

Similar Trials